Clinical Trial Results:
A single centre, randomised, partially-blind, placebo-controlled 3 way crossover pilot study investigating efficacy in terms of heartburn relief after taking (2x250mg) Gaviscon® chewable tablets, (1x20mg) Losec® MUPS® tablet and (2x) Placebo tablets in subjects with heartburn following a refluxogenic meal.
Summary
|
|
EudraCT number |
2010-019414-24 |
Trial protocol |
GB |
Global completion date |
18 Aug 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
11 Nov 2016
|
First version publication date |
11 Nov 2016
|
Other versions |
|
Summary report(s) |
2010-019414-24 Final CSR |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.